Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Inhibiting microRNAs Through ANTAGOMIRs

28.11.2008
An Experimental Strategy That Increases Vascularization And Reduces Infarct Size

What is a fruitful way to contain damages caused during an infarction? The answer is: trying to prevent/limit the action of damaging agents and promote the growth of new blood vessels that could help the recovery of damaged sites.

With this question (and answer) in mind, Stefanie Dimmeler Professor of Experimental Medicine and Head of the Molecular Cardiology at the University of Frankfurt and colleagues, set up their investigation on so-called microRNAs (miRNAs), small molecules involved in a number of critical processes including cardiovascular development, angiogenesis and inflammation.

During their study, the EVGN scientists identified a small group of promising miRNAs and developed an antagonist molecule called ANTAGOMIR that proved effective in blocking their noxious effects. These preliminary results were presented during the V Annual European Vascular Genomics Network Meeting held in Bad Hofgastein (Austria). Each year the Meeting convenes top scientists from all Europe and abroad, to discuss the state of the art and the most effective strategies and therapies in the field of Cardiovascular Disease (CVD).

miRNAs represent an attractive target for scientists who study CVD. Several investigations proved that they play a pivotal role, still to be defined, in cardiogenesis, cancer and in the regulation of complex processes. They are RNA molecules, but they do not carry any information useful for protein synthesis.

Their major role is to degrade specific mRNA molecules to prevent the assembly of selected proteins. Among their targets scientists have identified some proteins that promote angiogenesis (growth of blood vessels): when bound by miRNAs, these molecules are turned off and tissue damages can spread.

“The world of miRNAs is complex and articulated, so far several hundred molecules have been identified” underlined Stefanie Dimmeler in her presentation.

“Therefore we made a thorough screening and spotted a promising cluster in terms of activity on vessel remodelling and angiogenesis. When we checked for their presence we found that some of them were highly expressed in cells from patients with cardiac ischemia or coronary artery disease. This expression peaked at days 1-2 after ischemia. And other in vitro experiments suggested that these miRNAs hamper the repopulation of ischemic tissues by endothelial cells, a highly desirable event”.

So the scientists thought of developing an artificial molecule which was specular to the overall structure of some miRNAs, hence able to stick to them as the left and right hands of a person, in order to block their activity.

“We built an experimental ANTAGOMIR – said Dimmeler – in a way that it could adhere to several targets. The results were very promising, albeit still preliminary”. Some miRNAs were repressed – reported the researcher, and there was a good recovery of the heart functions in experimental laboratory models. “The extension of the infarcted site showed a significant reduction, paralleled by a restoration on the process of neovascularization”.

Now the German team plans to investigate in details if in the cluster analyzed there is one (or more) specific miRNA which is responsible of such effects, and to spot the molecular target(s) responsible for the therapeutic effects they observed.

For further information on this study please contact:
Cristina Serra
EVGN Press Office and Communication
cristina.serra@ifom-ieo-campus.it
Mobile: +39 338 4305210

Elena Bauer | alfa
Further information:
http://www.evgn.org/home
http://www.ifom-ieo-campus.it

More articles from Life Sciences:

nachricht One step closer to reality
20.04.2018 | Max-Planck-Institut für Entwicklungsbiologie

nachricht The dark side of cichlid fish: from cannibal to caregiver
20.04.2018 | Veterinärmedizinische Universität Wien

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>